Credit: Moderna. The approval was based on data from the phase 3 ConquerRSV trial, which included approximately 37,000 adults 60 years of age and older. The Food and Drug Administration (FDA) has ...

The CDC is monitoring influenza activity closely in states affected by the H5N1 outbreak and said there's been "no sign of unusual influenza activity." HealthDay News — Amid an ongoing outbreak of ...

The additional information provided by Regeneron and Sanofi was considered a major amendment to the application. The Food and Drug Administration (FDA) has extended the review period for the ...

Female doctor doing a medical examination. The focus is on the young pregnant woman being examined. Young pregnant woman on a visit to doctor. Having chest pain and breathing issues. This patient fact ...

Results from LIBRETTO-121 showed a confirmed overall response rate of 48% (95% CI, 28-69). The Food and Drug Administration (FDA) has granted accelerated approval to Retevmo (selpercatinib) for the ...

Among the 68 evaluable patients, the overall response rate was 85.3%, with 67.6% of patients achieving complete response and 17.6% achieving partial response. The Food and Drug Administration (FDA) ...

Highest risk of lymphoma was seen in individuals with less than 2 years between their first tattoo and the index year. HealthDay News — Tattoo exposure is associated with an increased risk of several ...

Onyda XR should not be substituted for other clonidine products on a mg-per-mg basis. The Food and Drug Administration (FDA) has approved Onyda XR (clonidine hydrochloride) extended-release oral ...

The proportionate increase in urinary albumin-to-creatinine ratio at 104 weeks was less in the semaglutide arm than the placebo arm. HealthDay News — Once-weekly subcutaneous semaglutide shows a ...

Risk reduction seen for overall CVD incidence for initiating statin therapy in both intention-to-treat and per-protocol analyses. HealthDay News — For patients aged 75 years and older, statin therapy ...

SPL84 is administered directly into the lungs where it is taken up by the cells and is expected to drive the production of fully functional CFTR proteins. The Food and Drug Administration (FDA) has ...

Etripamil is a calcium channel blocker designed to be administered intranasally to treat episodes of PSVT in an at-home setting. The Food and Drug Administration (FDA) has accepted for review the New ...